Joseph Kumka

Board Pearls

Health EN ↓ 116 episodes

Board Pearls is a gastroenterology board review built around clinical reasoning, not recall. Each episode takes one high-yield topic and works it the way you would on rounds: a case to anchor it, the framework that sorts the differential, and the specific decisions the exam rewards. The gastroenterology series covers the full blueprint across nine modules: esophagus, stomach and duodenum, small bowel, colon, pelvic floor, liver, pancreas and biliary, endoscopy, and the cross-cutting topics. Episodes are grouped by chapter and built from the primary guidelines and pivotal trials the boards draw...

Be sure to visit the podcast's website and support the creator: www.boardpearls.com

Author

Joseph Kumka

Category

Health

Podcast website

www.boardpearls.com

Latest episode

Jul 16, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Chapter 18, Ep 1 of 3: Acute Viral Hepatitis and the Fecal-Oral Viruses 16.07.2026

Episode one of the Viral Hepatitis chapter builds the acute-hepatitis framework and covers the two fecal-oral viruses, hepatitis A and hepatitis E. The organizing idea: acute viral hepatitis looks the same no matter which virus caused it, so you read the virus off the serology, not the symptoms. It walks the four clinical phases, the four-test acute panel with its two named traps, and then hepatit...

Chapter 17, Ep 2 of 2: Isolated Abnormalities, Imaging, and Biopsy 16.07.2026

Episode two of the Liver Test Interpretation chapter covers what to do when a single value is up with everything else normal, or when the labs aren't the bottleneck and imaging and fibrosis assessment are. Each case forces the same question in a different form: what's the next reflex test, and does it commit you to an invasive workup or excuse you from it? Isolated bilirubin splits on direct versu...

Chapter 17, Ep 1 of 2: The R Ratio and the Two Workup Tracks 16.07.2026

Episode one of the Liver Test Interpretation chapter turns abnormal liver enzymes into a workup by computing the R ratio and committing to a track before ordering another test. The organizing idea: which enzyme dominates and by how many multiples of normal it sits at frames the entire differential, because hepatocellular and cholestatic patterns share almost nothing. The hepatocellular track runs...

Chapter 16, Ep 3 of 3: Fecal Incontinence and Benign Anorectal Disorders 16.07.2026

Episode three covers fecal incontinence managed in a fixed sequence and the benign anorectal disorders anchored to the dentate line. Incontinence rarely fails for a single reason, so the workup canvasses the whole continence stack and the treatment runs from optimizing the modifiable factor through loperamide and biofeedback to sacral neuromodulation, which has displaced sphincteroplasty as first-...

Chapter 16, Ep 2 of 3: Dyssynergia and Slow-Transit Constipation 16.07.2026

Episode two covers the constipation phenotypes that need more than pharmacology: defecatory disorders diagnosed on anorectal manometry and balloon expulsion and treated with biofeedback, and slow-transit constipation documented on a marker or capsule study. The organizing discipline is to decide the mechanism before the next drug, because escalating laxatives in unrecognized outlet dysfunction pro...

Chapter 16, Ep 1 of 3: Chronic Constipation Pharmacology and OIC 16.07.2026

Episode one of the Pelvic Floor and Anorectal Disorders chapter works through chronic constipation as a symptom-defined syndrome, the empiric laxative sequence that resolves most patients, and the prescription drugs for refractory disease mapped to four molecular targets. The organizing idea: match the drug to the mechanism, and keep opioid-induced constipation separate because the enteric recepto...

Chapter 15, Ep 2 of 2: Diverticular Disease 12.07.2026

Diverticular disease as its own entity, following a management algorithm that shifted meaningfully in the last decade while the boards catch up. Uncomplicated diverticulitis is now an inflammatory process treated with selective rather than reflex antibiotics, and prophylactic resection by episode count is dead. Complicated disease grades on Hinchey and splits at the four-centimeter abscess thresho...

Chapter 15, Ep 1 of 2: CRC Screening Biology Treatment Polyps 12.07.2026

Episode one of two on the Colorectal Cancer, Polyps, and Diverticular Disease chapter, tracing the neoplastic pathway from average-risk screening through molecular subtyping to stage-based treatment and polyp surveillance. The organizing thread is mechanism: why screening starts at forty-five, why MLH1 loss reflexes to BRAF, and why histology sets the surveillance interval.   Topics covered Averag...

Chapter 14, Ep 3 of 3: Pouch Dysplasia EIM Pregnancy 12.07.2026

The long-arc complications of IBD after induction and maintenance: the ileal pouch and its inflammations, dysplasia surveillance in long-standing colitis, the extraintestinal manifestations, and pregnancy. The unifying board move is that active disease, not active medication, is the threat, so biologics usually continue through delivery. Localization, timing of surveillance, and whether a manifest...

Chapter 14, Ep 2 of 3: Crohn Complete 12.07.2026

Episode two of the IBD chapter takes Crohn disease from phenotype through complete medical management. It runs the Montreal classification into risk stratification and the top-down versus step-up decision, then walks Crohn-specific induction, immunomodulators, and biologic positioning. It closes with the phenotype-specific algorithms for perianal disease, strictures, and post-operative recurrence....

Chapter 14, Ep 1 of 3: UC Complete 12.07.2026

Episode one of three on inflammatory bowel disease, covering ulcerative colitis from classification through full medical management. Walks the UC-versus-Crohn distinction, the Mayo score driving severity-tiered therapy, the acute severe UC inpatient script with its day-three salvage rule, mesalamine for mild-to-moderate disease, and mechanism-based positioning of biologics and small molecules. Boa...

Chapter 13, Ep 2 of 2: IBS D Neuromod Bloating 12.07.2026

Episode two of the IBS and Functional Bowel chapter covers the diarrhea-predominant subtype, the neuromodulators and behavioral therapies that work across subtypes, and the mechanistic workup of bloating. Drug selection is mechanism-matched to the dominant symptom and driver, not subtype-matched in the abstract. Carry mechanism, subtype indication, and contraindication together to pick the right a...

Chapter 13, Ep 1 of 2: ROME IV Pathophys IBS C 12.07.2026

Episode one of two on Irritable Bowel Syndrome and functional bowel, covering positive diagnosis, Rome IV criteria, and subtyping. It maps the brain-gut model and its five mechanisms onto the drug classes. It closes with the mechanism-targeted pharmacology of constipation-predominant IBS.   Topics covered Rome IV positive diagnosis IBS subtyping by Bristol form Alarm features and targeted testing...

Chapter 12, Ep 2 of 2: BAM Microscopic Obscure 12.07.2026

Episode two of the Chronic Diarrhea and Malabsorption chapter works the patient who arrives after a clean standard workup. Three entities account for most of what the first pass missed: bile acid malabsorption, microscopic colitis, and a structured algorithm for obscure chronic diarrhea. Board-tested reasoning on typing, testing, and the trials that are diagnostic and therapeutic in one step.   To...

Chapter 12, Ep 1 of 2: Framework and Mechanism Workup 12.07.2026

Chronic diarrhea is too much stool water, and because normal absorptive efficiency runs near ninety-nine percent, small physiologic insults produce large clinical phenotypes. Episode one builds the four-mechanism framework, osmotic, secretory, fatty, and inflammatory, and lets that mechanism drive a staged workup. History, basic labs, stool studies, and endoscopy sort most patients within a few te...

Chapter 11, Ep 1 of 1: Small Bowel Mucosal 12.07.2026

What to think about when a small-bowel biopsy shows enteropathy and celiac has already been excluded on a gluten-containing diet. Walks the non-celiac differential mechanistically: wheat-related symptom syndromes, autoimmune enteropathy, Whipple disease, drug-induced enteropathies, checkpoint inhibitor enteritis, bacterial overgrowth, and tropical sprue. The histology, the medication list, and the...

Chapter 10, Ep 2 of 2: Refractory Celiac and Complications 12.07.2026

Most celiac patients failing a gluten-free diet are not refractory; they are eating hidden gluten or have a coexisting condition, so a structured non-responsive differential precedes any refractory workup. When refractory disease is genuine, the type one versus type two split on intraepithelial lymphocyte phenotype separates a steroid-responsive disease with good survival from a pre-lymphoma syndr...

Chapter 10, Ep 1 of 2: Celiac Diagnosis and Treatment 12.07.2026

Celiac disease built from mechanism through monitoring: modified gluten peptides bind HLA-DQ2/DQ8, drive T-cell inflammation, and trigger lymphocyte-mediated villous atrophy. The modern adult presents like IBS, iron deficiency, or an extraintestinal finding, so the threshold to test is broad. Diagnosis is serology-anchored and biopsy-confirmed while the patient still eats gluten, treated by a stri...

Chapter 9, Ep 2 of 2: Variceal and Unusual 12.07.2026

Episode two of the Upper GI Bleeding chapter covers acute variceal hemorrhage and the unusual non-variceal causes a routine scope misses. It anchors on the variceal bundle delivered before endoscopy, early TIPS for the high-risk cirrhotic, and the Sarin split for gastric varices. The second half is a recognition drill: each rare lesion is easy to treat once its history cue is named.   Topics cover...

Chapter 9, Ep 1 of 2: Nonvariceal UGIB 12.07.2026

Nonvariceal upper GI bleeding worked as a fixed sequence: perfusion first, diagnosis second, endoscopy third. The first hour moves mortality more than the scope does. Covers resuscitation, transfusion thresholds, pre-endoscopy pharmacology, risk scores, anticoagulant reversal, Forrest-directed endoscopic therapy, and post-hemostasis medical management.   Topics covered Resuscitation and airway in...

Chapter 8, Ep 2 of 2: CVS Pseudo FD 12.07.2026

Episode two of the Gastric and Small Bowel Motility chapter covers the episodic and functional presentations where the structural workup comes back clean and the pattern carries the diagnosis: cyclic vomiting syndrome, cannabinoid hyperemesis, chronic intestinal pseudo-obstruction, and functional dyspepsia. Reading dilated bowel or delayed emptying as mechanical disease misleads you every time. Ea...

Chapter 8, Ep 1 of 2: Gastroparesis 12.07.2026

Gastroparesis is one phenotype with three failure points: the vagus for accommodation and coordination, the interstitial cells of Cajal for rhythm, and smooth muscle for force. Diabetes hits two of the three, surgery hits the vagus, idiopathic disease hits the pacemaker, and drugs mimic the whole picture by slowing the antrum. Four-hour scintigraphy with strict drug holds and controlled glucose an...

Chapter 7, Ep 2 of 2: Gastric Tumors MALT NET GIST 12.07.2026

Episode two of the Gastritis and Gastric Cancers chapter works through the four gastric tumor families where histology and molecular driver are the discriminator: adenocarcinoma by Lauren type, MALT versus large B-cell lymphoma, the three gastric neuroendocrine tumors, and GIST as the model targeted-therapy cancer. Each tumor's biology drives its staging and its drug. Board-relevant triggers, mole...

Chapter 7, Ep 1 of 2: Atrophic Correa ZES 12.07.2026

Covers the chronic gastritides and precursor lesions of the stomach for boards, unified by what each disease does to gastrin. Teaches autoimmune atrophic gastritis, the H. pylori Correa cascade toward intestinal-type cancer, Menetrier disease, and Zollinger-Ellison syndrome. Emphasizes the two high-yield differentials: high gastrin sorted by gastric pH, and giant gastric folds sorted by acid outpu...

Chapter 3, Ep 3 of 3: Refractory Lyon Surgery Functional 10.07.2026

Drug failure on twice-daily acid suppression is not refractory reflux, it is a reason to work the patient up, and the workup usually turns up something other than reflux. The Lyon Consensus framework, with its acid-exposure cutoffs and symptom-association tests, sorts persistent symptoms into confirmed reflux, borderline, reflux hypersensitivity, and functional heartburn. Antireflux surgery is mat...

Listen to the Board Pearls podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.